India’s homegrown COVAXIN has drawn global attention

The indigenous vaccine of India has drawn global attention says ICMR that the Indian vaccine against #Covid-19, Covaxin, has drawn global attention.

“India’s indigenous vaccine against Covid19 Covaxine – a product of ICMR-Bharat Biotech collaboration, achieves the remarkable feat. Data generated from within India underlines impressive safety and immunogenicity profile of Covaxine and sparks Lancet’s interest in publishing them.” Tweets ICMR

The ICMR also said,” Encouraging Phase 1 and Phase 2 Covaxin trial results have paved the path for Phase 3 clinical trials in India, which is currently ongoing at 22 sites.”

Recommended For You